- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04418960
Physiological Changes of the Mitral Annulus After Annuloplasty in Barlow Disease
August 2, 2021 updated by: University Hospital, Basel, Switzerland
Physiological Changes of the Mitral Annulus After Annuloplasty in Barlow Disease: an MRI-focused Study
Barlow disease (BD) is a common cause of mitral insufficiency.
In 2012 the University Hospital of Basel started to perform a simplified mitral valve repair technique in BD just by implanting an annuloplasty-ring.
It is hypothesized that the major mechanism of the valvular insufficiency in Barlow disease is a deformation of the left ventricle and the posterior mitral annulus, causing its aberrant displacement during the systole towards posterior and basal and thus impairing the coaptation of the leaflets.
This prospective individual MRI study is to investigate the ventricle and the mitral annulus pre- and postoperatively for detailed analysis.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
10
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Martin Grapow, Prof. Dr. med.
- Phone Number: +41 44 3873711
- Email: grapow@herzzentrum.ch
Study Contact Backup
- Name: Thibault Schaeffer
- Phone Number: +41 61 328766
- Email: Thibault.schaeffer@usb.ch
Study Locations
-
-
-
Basel, Switzerland, 4031
- Recruiting
- Cardiac Surgery, University Hospital Basel
-
Contact:
- Martin Grapow, Prof. Dr. med.
- Phone Number: +41 44 3873711
- Email: grapow@herzzentrum.ch
-
Contact:
- Thibault Schaeffer
- Phone Number: +41 61 3285766
- Email: Thibault.Schaeffer@usb.ch
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients referred to cardiac surgery clinic (University Hospital Basel) through cardiologist meeting the inclusion criteria based on the medical history, clinical and echocardiographic findings.
Description
Inclusion Criteria:
- identified Barlow disease suffering from significant mitral insufficiency with indication to surgery
Exclusion Criteria:
- Active endocarditis or any other etiology of mitral insufficiency else than Barlow disease
- Inability to perform a cardiac MRI (e.g., metallic implants, claustrophobia)
- Pregnancy
- Inability to give consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in anatomical structures by MRI
Time Frame: The first MRI will be performed on the admission day before surgery. The second MRI will be performed during the hospital stay, between 3 and 7 days after the operation.
|
Change in anatomical structures by MRI: distance (mm) between the mitral annulus and the cardiac apex during the cardiac cycle before and after surgical correction
|
The first MRI will be performed on the admission day before surgery. The second MRI will be performed during the hospital stay, between 3 and 7 days after the operation.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
function of the mitral valve by echocardiography
Time Frame: during the hospital stay, between 3 and 7 days after the operation and at cardiological follow-up over the first 3 months.
|
association between reduction of movement of the posterior annulus and the function of the valve after surgery (i.e. its residual insufficiency (0 = absent, 1 = mild, 2 = moderate, 3 = severe)).
Evaluated with echocardiography as it is routinely performed in cardiac surgery.
|
during the hospital stay, between 3 and 7 days after the operation and at cardiological follow-up over the first 3 months.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Martin Grapow, Prof. Dr. med., HerzZentrum Hirslanden, Zurich
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 21, 2018
Primary Completion (Anticipated)
April 1, 2022
Study Completion (Anticipated)
April 1, 2022
Study Registration Dates
First Submitted
May 12, 2020
First Submitted That Met QC Criteria
June 2, 2020
First Posted (Actual)
June 5, 2020
Study Record Updates
Last Update Posted (Actual)
August 3, 2021
Last Update Submitted That Met QC Criteria
August 2, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018-02240; ch20Grapow
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mitral Insufficiency
-
Abbott Medical DevicesCompletedMitral Valve Regurgitation | Mitral Valve Incompetence | Mitral Insufficiency | Functional Mitral Regurgitation | Mitral Stenosis With InsufficiencyJapan
-
Universitätsklinikum Hamburg-EppendorfUniversity Hospital, Bordeaux; Montreal Heart InstituteRecruitingMitral Regurgitation | Mitral Valve Disease | Mitral Annular CalcificationSwitzerland, United States, Denmark, United Kingdom, France, Austria, Canada, Italy, Germany, Greece, Poland, Australia, Norway
-
Edwards LifesciencesActive, not recruitingMitral Regurgitation | Mitral Insufficiency | Mitral Repair | Mitral Valve | Annuloplasty | Edwards CardiobandSwitzerland, Germany, Italy
-
Edwards LifesciencesActive, not recruitingMitral Regurgitation | Mitral Insufficiency | Functional Mitral Regurgitation | Degenerative Mitral Valve DiseaseUnited States, Canada, Switzerland, Germany
-
Sun Yat-sen UniversityRecruitingMitral Insufficiency | Mitral Regurgitation (MR)China
-
4C Medical Technologies, Inc.RecruitingMitral Regurgitation | Mitral Valve Regurgitation | Mitral Valve Incompetence | Mitral Insufficiency | Mitral IncompetenceUnited States, Spain, Germany, Greece
-
Medtentia International Ltd OyCompletedMitral Regurgitation | Mitral InsufficiencyFinland
-
4C Medical Technologies, Inc.RecruitingMitral Regurgitation | Mitral Valve Regurgitation | Mitral Valve Incompetence | Mitral Insufficiency | Mitral IncompetenceUnited States
-
Abbott Medical DevicesCompletedMitral Regurgitation | Mitral Valve Insufficiency | Mitral Valve Regurgitation | Mitral Valve Incompetence | Mitral InsufficiencyUnited States
-
Abbott Medical DevicesCompletedMitral Regurgitation | Mitral Valve Insufficiency | Mitral Valve Regurgitation | Mitral Valve Incompetence | Mitral InsufficiencyUnited States
Clinical Trials on Magnetic resonance imaging (MRI)
-
University of CincinnatiActive, not recruitingProstate CancerUnited States
-
University of MichiganPhilips Healthcare; General ElectricCompleted
-
Abramson Cancer Center of the University of PennsylvaniaCompletedBrain TumorUnited States
-
American College of RadiologyPennsylvania Department of HealthCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedGlioma | Brain MassUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedThoracic Spine NeoplasmUnited States
-
University of California, San FranciscoTerminatedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
University of ArizonaNational Cancer Institute (NCI)CompletedBreast Cancer | Breast Carcinoma | Neuropathy | Neuropathy;PeripheralUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingExtensive Stage Lung Small Cell Carcinoma | Limited Stage Lung Small Cell Carcinoma | Lung Small Cell CarcinomaUnited States, Canada, Korea, Republic of, Saudi Arabia, Mexico, Chile, Colombia
-
Ohio State University Comprehensive Cancer CenterWithdrawn